Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-24

Clinical Trial Update: Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) pilot study evaluated peginterferon, ribavirin, and boceprevir given before liver transplantation to clear hepatitis C virus. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boceprevir (boceprevir)
  • Peginterferon (Pegylated interferon)
  • Ribavirin (ribavirin)

Snippet

Sponsor: Indiana University | Conditions: Liver Transplantation | EARLY_Phase 1 | Status: COMPLETED